Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Osteopontin may help hair follicle growth during the catagen phase.

Nonmelanoma skin cancers have higher levels of certain osteopontin variants than normal skin.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

Osteopontin levels are higher in people with androgenetic alopecia and are linked to metabolic disorders.

Understanding and targeting specific molecules can help reduce scarring and promote scar-free healing.

Botulinum toxin A can help improve thin endometrium and embryo implantation.

Balding and low testosterone increase risk of urinary stones.

Combining certain treatments, including FOL005, may improve healing of difficult wounds.

Current treatments for androgenetic alopecia are limited, but research is ongoing to find better solutions.

Blocking the HEDGEHOG-GLI1 pathway can reduce keloid growth and may be a potential treatment.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

Platelet-rich plasma is as effective as mineral trioxide aggregate for pulp capping and may offer better cellular responses.

Aged skin heals slower due to more inflammation and disrupted cell communication.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

CD34⁺ cells help heal damaged limbs by promoting blood vessel growth.

RANKL is crucial for bone health, immune function, and other body processes.

The Hedgehog signaling pathway is linked to cancer development, and targeting it with inhibitors shows promise but faces challenges like resistance.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Mesenchymal stem cells help heal wounds by using Cx43 hemichannels to improve tissue repair.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.